The 15th European AIDS Conference, organised by the European AIDS Clinical Society (EACS), took place in Barcelona, Spain, from 21-24 October 2015. NAM is the official provider of online science news.

Conference highlights

HIV treatment guidelines

With EACS release, all international HIV treatment guidelines agree on when to start – first time since 2006.

Conference bulletins

All our conference bulletins, available in English, French, Italian, Portuguese, Russian and Spanish.

HIV in Europe

Can Europe reach the 90-90-90 target for HIV treatment by 2020?

HIV and migration

The majority of migrants living with HIV in Europe may have acquired HIV in their new country.

HIV treatment

Benefits of early HIV treatment are clear, but issues raised by START and D:A:D remain unresolved.

TB treatment

Newest MDR-TB drug prices could fall by up to 95% through generic production.

Access to PrEP

When will Europe get PrEP (pre-exposure prophylaxis)?

Tuberculosis and HIV

TB death rate four times higher in Eastern Europe due to lack of HIV treatment after TB diagnosis.

PrEP side-effects

Modest bone loss seen in young men taking Truvada for pre-exposure prophylaxis.

aidsmap news from EACS 2015

← First12Next →

Editors' picks from other sources

News bulletins

Sign up for our email bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Official conference website

Find out more about the conference on the official conference website.

Visit the conference website >

aidsmap news apps

Keep up to date with the latest HIV news using the free aidsmap news iPhone and android apps.

Download the app >

NAM's coverage of the 15th European AIDS Conference has been made possible thanks to support from the European AIDS Clinical Society (EACS), Bristol-Myers Squibb, Gilead, Merck & Co., Inc., and ViiV Healthcare.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.